[go: up one dir, main page]

NO20011403D0 - Terapi for Õ forbedre kongestion - Google Patents

Terapi for Õ forbedre kongestion

Info

Publication number
NO20011403D0
NO20011403D0 NO20011403A NO20011403A NO20011403D0 NO 20011403 D0 NO20011403 D0 NO 20011403D0 NO 20011403 A NO20011403 A NO 20011403A NO 20011403 A NO20011403 A NO 20011403A NO 20011403 D0 NO20011403 D0 NO 20011403D0
Authority
NO
Norway
Prior art keywords
therapy
improve congestion
congestion
improve
Prior art date
Application number
NO20011403A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011403L (no
Inventor
Paul Leonce Irma De Nijs
Wim Louis Julien Parys
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20011403D0 publication Critical patent/NO20011403D0/no
Publication of NO20011403L publication Critical patent/NO20011403L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20011403A 1998-10-16 2001-03-20 Terapi for å forbedre kongestion NO20011403L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203454 1998-10-16
PCT/EP1999/007804 WO2000023057A2 (en) 1998-10-16 1999-10-12 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition

Publications (2)

Publication Number Publication Date
NO20011403D0 true NO20011403D0 (no) 2001-03-20
NO20011403L NO20011403L (no) 2001-03-20

Family

ID=8234219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011403A NO20011403L (no) 1998-10-16 2001-03-20 Terapi for å forbedre kongestion

Country Status (20)

Country Link
EP (1) EP1121131A2 (xx)
JP (1) JP2002527469A (xx)
KR (1) KR20010072878A (xx)
CN (1) CN1367697A (xx)
AU (1) AU6472799A (xx)
BG (1) BG105302A (xx)
BR (1) BR9914419A (xx)
CA (1) CA2345767A1 (xx)
EE (1) EE200100136A (xx)
HK (1) HK1039745A1 (xx)
HR (1) HRP20010262A2 (xx)
HU (1) HUP0103781A3 (xx)
ID (1) ID28441A (xx)
IL (1) IL142588A0 (xx)
NO (1) NO20011403L (xx)
PL (1) PL348107A1 (xx)
SK (1) SK4592001A3 (xx)
TR (1) TR200101082T2 (xx)
WO (1) WO2000023057A2 (xx)
ZA (1) ZA200103081B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006201188B2 (en) * 2001-02-05 2007-11-15 Novartis Ag New use of iloperidone
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
CA2463158C (en) * 2001-10-30 2013-07-30 Novartis Ag Depot formulations of iloperidone and a star polymer
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
WO2006065233A1 (en) * 2004-12-10 2006-06-22 Abbott Laboratories Fused bicycloheterocycle substituted quinuclidine derivatives
US20050232990A1 (en) * 2003-12-31 2005-10-20 Garth Boehm Donepezil formulations
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
CN101668525A (zh) 2007-03-01 2010-03-10 前体生物药物股份公司 谷氨酰胺酰环化酶抑制剂的新用途
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
MX2007008642A (es) * 2007-07-16 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias.
EA037187B1 (ru) 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
CA2789440C (en) 2010-03-10 2020-03-24 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
JP5945532B2 (ja) 2010-04-21 2016-07-05 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ, インコーポレイテッド 認知機能を改善するための方法および組成物
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020327A1 (en) * 1991-05-14 1992-11-26 Ernir Snorrason Treatment of fatigue syndrome with cholinesterase inhibitors
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
CA2300148C (en) * 1997-08-11 2009-06-23 University Of South Florida Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
CA2328197C (en) * 1998-04-14 2007-11-20 The General Hospital Corporation Methods for treating neuropsychiatric disorders

Also Published As

Publication number Publication date
AU6472799A (en) 2000-05-08
KR20010072878A (ko) 2001-07-31
HUP0103781A2 (hu) 2002-03-28
WO2000023057A3 (en) 2000-07-27
EP1121131A2 (en) 2001-08-08
ZA200103081B (en) 2002-07-12
HK1039745A1 (zh) 2002-05-10
HUP0103781A3 (en) 2003-09-29
IL142588A0 (en) 2002-03-10
PL348107A1 (en) 2002-05-06
WO2000023057A2 (en) 2000-04-27
SK4592001A3 (en) 2001-12-03
BG105302A (en) 2001-11-30
ID28441A (id) 2001-05-24
CA2345767A1 (en) 2000-04-27
EE200100136A (et) 2002-06-17
TR200101082T2 (tr) 2001-09-21
BR9914419A (pt) 2001-06-26
JP2002527469A (ja) 2002-08-27
CN1367697A (zh) 2002-09-04
NO20011403L (no) 2001-03-20
HRP20010262A2 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
NO20011403D0 (no) Terapi for Õ forbedre kongestion
IS6340A (is) Vatnsgel-knúið lyfjaskammtaform
ID27841A (id) Turunan-turunan biaril terapeutik
NO20003640D0 (no) Ny doseringsform
DE59910140D1 (de) Gleitschalungsfertiger
ID26974A (id) Ketoenol siklik arilfenil-tersubstitusi
DK1637127T3 (da) Terapeutisk mikroskum
NO992692D0 (no) Nefadozon doseringsform
DE69941252D1 (de) Geriffelte elektroden
ATE321483T1 (de) Dose
FR2806140B1 (fr) Volant divise
DE69936958D1 (de) Verkehrsformer
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
ID28648A (id) Perangkat penyerapan inter-labial
DE69921571D1 (de) Massagegerät
EE200200568A (et) Ravis kasutatavad difenüüleetriühendid
IS6563A (is) Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka
DE60037935D1 (de) Kontinuierliches behandlungssystem
NO20005042D0 (no) FremgangsmÕter for Õ inhibere MRP1
NO994872D0 (no) Reisesafe
IT1310385B1 (it) Dispositivo per migliorare la respirazione.
NO20023164L (no) Buekonstruksjon
IS5877A (is) Ný efnablanda
IS5879A (is) Ný efnablanda
IT1299030B1 (it) Dispositivo per produrre scarpe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application